Phathom Pharmaceuticals, Inc. PHAT Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s accounts receivable?
- Phathom Pharmaceuticals, Inc. (PHAT) reported accounts receivable of $80.72M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s accounts receivable increased by 122.0% year-over-year, from $36.36M to $80.72M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.